See also this year's filing and all EDGAR filings for this company.
PDF Report 0001168220_2017_Altrazeal_Life_Sciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001168220, Altrazeal Life Sciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 793,397 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 216,781 |
| 2 | PropertyPlantAndEquipmentNet | 126,741 |
| 3 | remainder_Assets | 3,199,156 |
| 4 | LiabilitiesCurrent | 2,407,788 |
| 5 | LiabilitiesNoncurrent | 358,462 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,308,759 |
| 9 | ResearchAndDevelopmentExpense | 445,404 |
| 10 | remainder_Expenses | 3,151,268 |
| 11 | remainder_Revenues | 442,565 |
| 12 | remainder_NetIncome | 9,240 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,336,075 |
| 1 | Liabilities | 2,766,250 |
| 2 | Expenses | 4,905,431 |
| 3 | Revenues | 442,565 |
| 4 | StockholdersEquity | 1,569,825 |
| 5 | NetIncome | -4,453,626 |
| 6 | ComprehensiveNetIncome | -4,453,626 |
| 7 | BaseVar | 6,229,780 |
| 8 | EconomicCapitalRatio | -0.494 |
Edgar->Model Mapping
Feature Distribution
